Effects of Vildagliptin on Glucose Control in Patients with Type 2 Diabetes Inadequately Controlled With Metformin

Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 6

Abstract

Aim and Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes. Patient selection and method: The study was done in 100 patients of Type 2 DM who were inadequately controlled by metformin alone. Strict predefined inclusion and exclusion criteria were followed and each patient was monitored with physical examination including body weight and blood pressure, complete blood count, fasting blood glucose and post prandial blood glucose, HbA1c, lipid profile (TC, LDL – C, HDL – C, triglycerides), renal profile (B Urea, S Creatinine, routine urine examination, ACR – urine, test for microalbuminemia), liver profile (ALT, AST, ALP, S.Bilirubin, S Protein) and ECG. Efficacy and tolerability were assessed in eight visits over 24 weeks. Results: The decrease of mean HbA1c level was 1.13% in cases (Group A) as compared to 0.05% in the control (Group B) at 24 week which was found to be significant (P value <0.01). Reduction in the mean fasting blood glucose level in cases (Group A) was 28.83mg/dL as compared to 3.6mg/dL in control (Group B) at 24 weeks. This decrease was found to be significant (P value <0.01). Reduction in the mean post prandial blood glucose level in cases (Group A) was 41.44mg/dL as compared to 2.12mg/dL in control (Group B) at 24 week. This decrease was found to be significant (P value <0.01). No major changes from baseline to endpoint were observed for any hematological, biochemical or urinalysis parameter. Conclusion: Vildagliptin is well tolerated and produces clinically meaningful, dose-related decreases in A1C and FPG as add-on therapy in patients with type 2 diabetes inadequately controlled by metformin.

Authors and Affiliations

Dr Abhishek Anand

Keywords

Related Articles

Quality of Life among Patients after Vaginal Hysterectomy and Pelvic Floor Repair Operation

Objective: To find out the complications affecting the quality of life after vaginal hysterectomy and pelvic floor repair operation. Methods and Materials: This is a prospective cross sectional study enrolled from Obstet...

Low Frequency Ultrasonic Versus Microcurrent Effect on Tissue Healing After Tendon Suture

Background: Tendon injury has poor healing process. Therapeutic US has a positive role to play in providing the growth factors, also Microcurrent therapy has been used to increase the rate of healing. Purpose: this study...

Quality of Life among Post-Menopausal Women in Rural area of Punjab

Background: Menopause is a physiological process in women's life. The transition through menopause is a life event that can profoundly affect quality of life. Aims & Objectives: To assess the menopausal related symptoms...

Effect of Behavioral and Biological Interventions on Malaria Control in Endemic areas of Rajasthan

Background: Malaria is one of the important public health problems of African and south east Asian countries including India which contributes to approximately 75% of malaria cases in South East Asia. Some areas of state...

Comparative Study of Atorvastatin and Rosuvastatin on Serum Lipid Profile in Cardiac Patients with Diabetes

Hyperlipidemia is a disorder of lipoprotein metabolism, which includes a number of abnormalities such as hypercholesterolemia and hypertriglyceridemia. Recently World Health Organization (WHO) has declared that by 2020,...

Download PDF file
  • EP ID EP209089
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Dr Abhishek Anand (2015). Effects of Vildagliptin on Glucose Control in Patients with Type 2 Diabetes Inadequately Controlled With Metformin. Journal of Medical Science And clinical Research, 3(6), 5963-5976. https://europub.co.uk./articles/-A-209089